Clinicopathologic significance of GLUT1 expression and its correlation with Apaf-1 in colorectal adenocarcinomas

doi:10.3748/wjg.v17.i14.1866

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 14

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4194)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-3) series.

Item

Count

PDF

371

HTML

3341

Figures (1-3)

241

Tables (1-3)

242

Sum=4195

Apr 14, 2011 (publication date) through Dec 23, 2024

Times Cited of This Article

Times Cited (32)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Apr 14, 2011; 17(14): 1866-1873
Published online Apr 14, 2011. doi: 10.3748/wjg.v17.i14.1866

Full Size Figure Download Figure

Figure 2 Representation showing the difference of mean grading score of glucose transporter 1 expression in normal mucosa, tubular adenomas with low grade dysplasia, tubular adenomas with high grade dysplasia, adenocarcinomas, and metastatic lesions (lymph nodes and distant organs). One-way ANOVA test was used. GLUT1: Glucose transporter 1; LGD: Low grade dysplasia; HGD: High grade dysplasia.

Citation: Jun YJ, Jang SM, Han HL, Lee KH, Jang KS, Paik SS. Clinicopathologic significance of GLUT1 expression and its correlation with Apaf-1 in colorectal adenocarcinomas. World J Gastroenterol 2011; 17(14): 1866-1873
URL: https://www.wjgnet.com/1007-9327/full/v17/i14/1866.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i14.1866